Daratumumab Plus Pomalidomide and Dexamethasone Improved PFS in Rel/Ref Multiple Myeloma
Overall survival data were not mature.
Multiple Myeloma
Dose/Schedule-Adjusted Lenalidomide-Dexamethasone Shows Positive Survival Outcomes in Multiple Myeloma
Researchers sought to determine whether treatment with dose/schedule-adjusted Rd would have similar survival outcomes seen with continuous Rd therapy in patients with multiple myeloma.
Carfilzomib Therapies Effective for Patients With Relapsed/Refractory Multiple Myeloma
Researchers sought to determine whether combination therapies with carfilzomib would be feasible for patients with relapsed/refractory multiple myeloma.
Triplet Is ‘New Standard of Care’ for Relapsed/Refractory Multiple Myeloma
Adding isatuximab to carfilzomib and dexamethasone improved outcomes.
How Knowledge of Treatment Assignment Affects Patient Reported Data in Multiple Myeloma Clinical Trials
Researchers sought to determine if knowing treatment assignment would lead to patient bias among participants in multiple myeloma clinical trials.
Young Patients With Multiple Myeloma May Benefit From Tandem Autologous Hematopoietic Stem Cell Transplantation
Researchers sought to determine whether tandem ASCT would improve outcomes in patients younger than 40 years old with multiple myeloma.
Model Estimates Little Impact on US Payer Budgets by the Use of Selinexor, Bortezomib, Dexamethasone in Previously-Treated Multiple Myeloma
Researchers sought to determine the budget impact of using selinexor, bortezomib, and dexamethasone for the treatment of patients with previously treated multiple myeloma.
Real-World Analysis of Renal Function in Patients With Multiple Myeloma
Researchers sought to determine the real-world renal function and outcomes for patients with multiple myeloma according to type of treatment and line of therapy.
Plasma Biomarkers May Help Target CAR-T Therapy for Multiple Myeloma
Researchers sought to determine whether plasma biomarkers may help enhance CAR-T therapy for patients with multiple myeloma.
Mobile Wearable Devices Show Some Sleep Disturbances During Multiple Myeloma Treatment
Younger patients had a significant decrease in sleep time on days they received dexamethasone.
- Loading...
Loading...
Next post in Myeloma
Loading... 
Loading...